Hakutulokset - Jan Petrášek
- Näytetään 1 - 20 yhteensä 25 tuloksesta
- Siirry seuraavalle sivulle
-
1
Gut–liver axis and sterile signals in the development of alcoholic liver disease Tekijä Gyöngyi Szabó, Jan Petrášek
Julkaistu 2017Revisão -
2
Innate Immunity and Alcoholic Liver Disease Tekijä Gyöngyi Szabó, Jan Petrášek, Shashi Bala
Julkaistu 2012Revisão -
3
Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease Tekijä Jan Petrášek, Pranoti Mandrekar, Gyöngyi Szabó
Julkaistu 2010Artigo -
4
-
5
The Unfolding Web of Innate Immune Dysregulation in Alcoholic Liver Injury Tekijä Gyöngyi Szabó, Pranoti Mandrekar, Jan Petrášek, Donna Catalano
Julkaistu 2011Revisão -
6
Gut-Liver Axis and Sensing Microbes Tekijä Gyöngyi Szabó, Shashi Bala, Jan Petrášek, Arijeet K. Gattu
Julkaistu 2010Revisão -
7
-
8
-
9
MicroRNA Expression Profile in Lieber‐DeCarli Diet‐Induced Alcoholic and Methionine Choline Deficient Diet‐Induced Nonalcoholic Steatohepatitis Models in Mice Tekijä Angela Dolganiuc, Jan Petrášek, Karen Kodys, Donna Catalano, Pranoti Mandrekar, Arumugam Velayudham, Gyöngyi Szabó
Julkaistu 2009Artigo -
10
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice† Tekijä Arumugam Velayudham, Angela Dolganiuc, Michael Peter Ellis, Jan Petrášek, Karen Kodys, Pranoti Mandrekar, Gyöngyi Szabó
Julkaistu 2008Artigo -
11
-
12
-
13
-
14
Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice Tekijä Bharath Nath, Ivan Levin, Tímea Csák, Jan Petrášek, Christian Mueller, Karen Kodys, Donna Catalano, Pranoti Mandrekar, Gyöngyi Szabó
Julkaistu 2011Artigo -
15
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases Tekijä Shashi Bala, Jan Petrášek, Shiv Mundkur, Donna Catalano, Ivan Levin, Jeanine Ward, Hawau Alao, Karen Kodys, Gyöngyi Szabó
Julkaistu 2012Artigo -
16
STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease Tekijä Jan Petrášek, Arvin Iracheta‐Vellve, Tímea Csák, Abhishek Satishchandran, Karen Kodys, Evelyn A. Kurt‐Jones, Katherine A. Fitzgerald, Gyöngyi Szabó
Julkaistu 2013Artigo -
17
Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease Tekijä Jan Petrášek, Arvin Iracheta‐Vellve, Banishree Saha, Abhishek Satishchandran, Karen Kodys, Katherine A. Fitzgerald, Evelyn A. Kurt‐Jones, Gyöngyi Szabó
Julkaistu 2015Artigo -
18
Cell wall contributes to the stability of plasma membrane nanodomain organization of <i>Arabidopsis thaliana</i> FLOTILLIN2 and HYPERSENSITIVE INDUCED REACTION1 proteins Tekijä Michal Daněk, Jindřiška Angelini, Kateřina Malínská, Jan Andrejch, Zuzana Amlerová, Daniela Kocourková, Jitka Brouzdová, Olga Valentová, Jan Martinec, Jan Petrášek
Julkaistu 2019Artigo -
19
Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells Tekijä Jan Petrášek, Angela Dolganiuc, Tímea Csák, Bharath Nath, István Hritz, Karen Kodys, Donna Catalano, Evelyn A. Kurt‐Jones, Pranoti Mandrekar, Gyöngyi Szabó
Julkaistu 2010Artigo -
20
Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice Tekijä Arvin Iracheta‐Vellve, Jan Petrášek, Abhishek Satishchandran, Benedek Gyöngyösi, Banishree Saha, Karen Kodys, Katherine A. Fitzgerald, Evelyn A. Kurt‐Jones, Gyöngyi Szabó
Julkaistu 2015Artigo
Työkalut:
Liittyvät aiheet
Medicine
Internal medicine
Biology
Immunology
Biochemistry
Inflammation
Liver injury
Alcoholic liver disease
Cirrhosis
Endocrinology
Chemistry
Disease
Fatty liver
Innate immune system
Cell biology
Immune system
Alcoholic hepatitis
Gene
Steatohepatitis
TLR4
Hepatocyte
In vitro
Receptor
Inflammasome
Liver disease
Proinflammatory cytokine
Steatosis
Toll-like receptor
IRF3
Pharmacology